Anti-cervical cancer vaccine by SII Current Affairs, GK & News
SII: Anti-cervical cancer vaccine
On July 12, 2022, the CEO of Serum Institute of India (SII) Adar Poonawalla announced company’s plans to roll out its indigenously-developed vaccine for the prevention of cervical cancer among women. Highlights The Drugs Controller General of India (DCGI) has also accorded the market authorisation to SII for manufacturing the vaccine for cervical cancer. It will be ..
Month: Current Affairs - July, 2022
Category: Science & Technology Current Affairs
Topics: Anti-cervical cancer vaccine by SII • Cervical cancer in India • Drugs Controller General of India (DCGI) • National Cancer Control Programme (NCCP) • Serum Institute of India (SII)